Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duac Gel versus Differin Gel for mild to moderate acne vulgaris
2004-002272-41Phase 4Completed
- Sponsor
- Stiefel Laboratories
- Start
- Jun 2005
- Modality
- Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, single-blind trial of clindamycin phosphate + benzoyl peroxide and adapalene in acne vulgaris (2 arms), sponsored by Stiefel Laboratories. Primary endpoint: Percentage change from baseline of inflammatory lesion counts. Started Jun 2005; status: completed.
02
Drugs
clindamycin phosphate + benzoyl peroxideadapalene
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on 2004-002272-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002272-41.